Ellen J Beswick

5PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersTumour immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2025
MK2 Inhibition in CD4+ T Cells Protects Against IFNγ and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models.

Cody S Howe, Marina Chulkina, Ryan Syrcle

|May 22, 2024
Mucosal-associated invariant T cells modulate innate immune cells and inhibit colon cancer growth.

Olivia J Cheng, Eric J Lebish, Owen Jensen

|Dec 09, 2022
Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer.

Romain Villéger, Marina Chulkina, Randy C Mifflin

|Nov 14, 2022
Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils.

Damian Jacenik, Ioannis Karagiannidis, Ellen J Beswick

|Sep 15, 2020
Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.

Aaron C Petrey, Fares Qeadan, Elizabeth A Middleton

Pageof 1

Frequent Collaborators

2 joint publications

Damian Jacenik

1 joint publications

Irina V Pinchuk

1 joint publications

Olivia J Cheng

1 joint publications

Eric J Lebish